Study of the Application of Nafamostat Mesylate in Continuous Renal Replacement Therapy in Patients with Coagulation Dysfunction-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Study of the Application of Nafamostat Mesylate in Continuous Renal Replacement Therapy in Patients with Coagulation Dysfunction

Published:2023 Issue:03 Volume:13 Page:3808-3814
ISSN:2161-8712
Container-title:Advances in Clinical Medicine
language:
Short-container-title:ACM

Author:

卢自文

Publisher

Hans Publishers

Subject

General Engineering

Reference31 articles.

1. 孙菲菲, 吉挺. 低分子肝素抗凝在连续肾脏替代治疗中的应用效果[J]. 护理研究, 2022, 36(17): 3116-3120.

2. AN69ST membranes adsorb nafamostat mesylate and affect the management of anticoagulant therapy: a retrospective study

3. Clinical study of blood purification therapy in critical care in Japan: results from the survey research of the Japan Society for Blood Purification in Critical Care in 2013

4. Review of Anticoagulation in Continuous Renal Replacement Therapy

5. Murdeshwar, H.N. and Anjum, F. (2022) Hemodialysis. StatPearls Publishing, Treasure Island.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP